±Û ¼öÁ¤Çϱâ
±Û¾´ÀÌ
E-mail
Homepage
±ÛÁ¦¸ñ
±Û
I'm a member of a gym
government research paper
LONDON, Sept 20 (Reuters) - An experimental drug forDuchenne muscular dystrophy (DMD) from GlaxoSmithKline and Prosensa failed to meet its goal in a late-stageclinical trial, sending shares in Prosensa tumbling 70 percent.
ºñ¹Ð¹øÈ£
(¼öÁ¤°ú »èÁ¦½Ã ÇÊ¿ä!! )